AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitazion-M Tablet

Prescription Icon
Prescription Required

Marketer

Ayansh Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitazion-M Tablet

Combiflex-D tablets combine two active ingredients to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like vision impairment and kidney dysfunction, potentially lowering the risk of cardiovascular events like stroke or heart attack. Combiflex-D may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with adherence to a balanced diet and consistent physical activity. Dosage is personalized based on your health status, glucose levels, and concurrent medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Maintaining the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly impact control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to identify and manage this risk. This medication isn't suitable for all patients. Inform your physician of any pre-existing conditions such as hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption before initiating treatment. Pregnant or lactating individuals should seek medical advice prior to use. Potential drug interactions exist; disclose all medications to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood sugar levels throughout the treatment period.

Primary Ingredients of Sitazion-M Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Sitazion-M Tablet

Managing type 2 diabetes

Major Benefits of Sitazion-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sitazion-M Tablet with a meal.

Common Side effects of Sitazion-M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitazion-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. It's recommended to take Sitazion-M Tablet with a meal.

How Sitazion-M Tablet works:

Sitagliptin and metformin, the components of Sitazion-M tablets, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Sitazion-M Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitazion-M tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitazion-M tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitazion-M tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitazion-M tablet use. Physician consultation is necessary. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should not take Sitazion-M Tablets; its use is considered unsafe and requires medical consultation.

What if you forget to take Sitazion-M Tablet :

Should you forget a Sitazion-M Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitazion-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitazion-M Tablet

Sitazion-M tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitazion-M Tablet use can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitazion-M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitazion-M Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitazion-M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the label's instructions. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Sitagliptin + Metformin (Sitazion-M Tablet) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitazion-M and seek immediate medical attention.
Sitazion-M Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitazion-M Tablet may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitazion-M Tablet components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitazion-M tablets and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitazion-M) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If these occur, discontinue Sitazion-M and seek immediate medical attention.
Prolonged Sitazion-M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes including balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Sitazion-M Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitazion-M Tablet may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitazion-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazion-M tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitazion-M) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding Sitagliptin/Metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitazion-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). To mitigate these risks, supplemental vitamin B12 is recommended at least annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitazion-M Tablet
167